Literature DB >> 6613982

Estimators of relative risk for case-control studies.

C J Hogue, D W Gaylor, K F Schulz.   

Abstract

The odds ratio from a case-control study of the "cumulative-incidence" type can be used as an estimate of the relative risk of a disease attributable to exposure to an agent only when the incidence of the disease is low. The odds ratio can be modified to obtain an accurate estimate of the relative risk, regardless of the incidence of the disease. This modification of the odds ratio can be performed with any one of four types of auxiliary information: overall probability of disease, probability of disease in the unexposed population, probability of disease in the exposed population, or overall probability of exposure. For "incidence density" case-control studies, the odds ratio equals the relative risk when the estimate of exposure in the comparison group can be considered to be an estimate of the overall probability of exposure in the population at risk. Under certain conditions, such "case-exposure" studies may be preferable to cohort studies and to cumulative-incidence case-control studies. The authors present an approach to hypothesis testing for crude and stratified data from a case-exposure study.

Mesh:

Year:  1983        PMID: 6613982     DOI: 10.1093/oxfordjournals.aje.a113646

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Atopic conditions other than asthma and risk of the 2009 novel H1N1 infection in children: a case-control study.

Authors:  Carlos F Santillan Salas; Sonia Mehra; Maria R Pardo Crespo; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

Review 2.  The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Suhag Patel; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2014-02       Impact factor: 3.062

3.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

4.  Increased risk of pertussis in patients with asthma.

Authors:  Conrad R Capili; Allison Hettinger; Natalie Rigelman-Hedberg; Lisa Fink; Thomas Boyce; Brian Lahr; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

Review 5.  Study designs and potential biases in sports injury research. The case-control study.

Authors:  M Schootman; J W Powell; J C Torner
Journal:  Sports Med       Date:  1994-07       Impact factor: 11.136

6.  Health effects of attending a public swimming pool: follow up of a cohort of pupils in Paris.

Authors:  I Momas; F Brette; A Spinasse; F Squinazi; W Dab; B Festy
Journal:  J Epidemiol Community Health       Date:  1993-12       Impact factor: 3.710

7.  Infant feeding and risk of severe diarrhoea in Basrah city, Iraq: a case-control study.

Authors:  D A Mahmood; R G Feachem; S R Huttly
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 8.  The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Prateek Lohia; Chetna Jinjuvadia; Sergio Montoya; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2013-01       Impact factor: 3.062

9.  The Influence of Screening for Precancerous Lesions on Family-Based Genetic Association Tests: An Example of Colorectal Polyps and Cancer.

Authors:  Stephanie L Schmit; Jane C Figueiredo; Victoria K Cortessis; Duncan C Thomas
Journal:  Am J Epidemiol       Date:  2015-08-24       Impact factor: 4.897

10.  Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial.

Authors:  Reid W D Farris; Noel S Weiss; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.